Head-to-Head: which pill tames high blood pressure better in younger adults?
NCT ID NCT07327749
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study tested two different blood pressure treatments in 59 adults under 60 who were newly diagnosed with hypertension. One group took bisoprolol alone, while the other took a combination pill containing valsartan and amlodipine. The goal was to see which approach better controlled blood pressure over 24 hours, including nighttime readings. Researchers also tracked any side effects reported by participants.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
bisoprolol and a valsartan-amlodipine combination pill
What this could lead to
If one drug works better, it could offer a simpler or more effective first-choice treatment for high blood pressure in younger adults.
What could go wrong
This is a small, completed Phase 4 trial with only 59 participants, so results may not apply to everyone. Both drugs have known side effects like dizziness or fatigue.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
professor Kojuri cardiology clinic
Shiraz, Fars, 55318, Iran